Flavonols: Metabolism, Bioavailability, and Health Impacts

Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology

Volumn , Issue , 2009, Pages 185-196

  Terao, Junji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Conjugated quercetin metabolites and biological activities; Flavonol metabolism, bioavailability and health impacts; Flavonols antioxidant and pro oxidant activity

Indexed keywords

EID: 77549087040     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470531792.ch8     Document Type: Chapter

References (53)

1. Bjeldans LF, Chang GW. 1977. Mutagenic activity of quercetin and related compounds. Science 197:577-578.
2. Bokkenheuse VD, Shacketon CHL, Winter J. 1987. Hydrolysis of dietaryflavonoide glycosides by strains of intestinal bacteroides from humans. Biochem J 248:953-956.
3. Bors W, Heller W, Michel C, Saran M. 1990. Flavonoids as antioxidants: Determination of radical-scavenging efficiencies. In: Packer L, Glazer AN, Eds. Methods in Enzymology 186, San Diego: Academic Press, pp. 343-355.
4. Crozier A, Jaganath IB, Cliford MN. 2006. Phenols, polyphenols and tannins: An overview. In: Crozier A, Clifford MN, Ashihaea H, Ed. Plant Secondary Metabolites. Oxford: Blackwell, pp. 1-24.
5. Day AJ, Mellon F, Barron D, Sarrazin G, Morgan MRA, Williamson G. 2001. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic Res 35:941-952.
6. Day AJ, Canada FJ, Diaz JC, Kroon PA, Mclauchlan R, Faulds CB, Plumb GW, Morgan MR, Williamson G. 2000a. Dietary flavonoid and isoflavone glycosides are hydrolyzed by the lactase site of lactase phlorizin hydrolase. FEBS Lett 468:166-170.
7. Day AJ, Bao Y, Morgan MRA, Williamson G. 2000b. Conjugation position of quercetin glucuronide and effect on biological activity. Free Radic Biol Med 29:1234-1243.
8. Day AJ, Dupont MS, Ridley S, Rhodes M, Rhodes MJC, Morgan MRA, Williamson G. 1998. Deglucosidation of flavonoid and isoflavonoid glycosides by human small intestine and liver b-glucosidase activity. FEBS Lett 436:71-75.
9. de Boer VC, Dihal AA, Arts IC, Wolffram S, Alink GM, Rietjens IM, Keijer J, Hollman PC. 2005. Tissue distribution of quercetin in rats and pigs. J Nutr 135:1718-1725.
10. de Pascual-Teresa S, Johnston KL. Dupont MS, O'leary KA, Needs PW, Morgan LM, Clifford MN, Bao Y, Williamson G. 2004. Quercetin metabolism downregulate cyclooxygenase-2 transcription in human lymphocytes ex vivo but not in vivo. J Nutr 134:552-557.
11. Dufour C, Dangles O. 2005. Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy. Biochim Biophys Acta 1721:164-173.
12. Frei B, Stocker R, Ames, BN. 1988. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 85:9748-9752.
13. Galati G, O'Brien PJ. 2004. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic Biol Med 37:287-303.
14. Gouphua C, Sofic E, Prior RL. 1997. Antioxidant and prooxidant behavior of flavonoids: Structure-activity relationships. Free Radic Biol Med 22:749-760.
15. Hertog, MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. 1993. Antioxidant flavonols and coronary heart disease risk. Lancet 342:1007-1011.
16. Hollman PC, de Vries JH, van Leeuwen SD, Mengelers MJ, Katan MS. 1995. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 62:1276-1282.
17. Hong, Y-J, Mitchell E. 2005. Metabolic profiling of flavonol metabolites in human urine by liquid chromatography and tandem mass spectrometry. J Agric Food Chem 52:6794-6801.
18. Ioku K, Pongpiriyadacya Y, Konishi Y, Takei Y, Nakatani N, Terao J. 1998. b-glucosidase activity in the rat small intestine toward quercetin monoglucosides. Biosci Biotecnol Biochem 63:1428-1431.
19. Kawai Y, Nishikawa T, Shiba T, Saito S, Murota K, Shibata N, Kobayashi M, Kanayama M, Uchida K, Terao J. 2008. Macrophages as a target of quercetin glucuronides in human atherosclerotic arteries. J Biol Chem 283:9424-9434.
20. Kawanishi S, Oikawa S, Murata M. 2005. Evaluation for safety of antioxidant chemopreventive agents. Antioxid Redox Signal 7:1728-1739.
21. Kim DS, Takai H, Arai M, Araki S, Mezawa M, Kawai Y, Murota Y, Terao J, Ogata Y. 2007. Effect of quercetin and quercetin 3-glucuronide on the expression of bone sialoprotein gene. J Cell Biochem 101:790-800.
22. Konishi Y. 2005. Transepithelial transport of microbial metabolites of quercetin in intestinal Caco-2 cell monolayers. J Agric Food Chem 53:601-607.
23. Manach C, Morand C, Demigne C, Texier O, Regerat F, Rémésy, C. 1997. Bioavailability of rutin and quercetin in rats. FEBS Lett 409:12-16.
24. McAnlis GT, McEneny J, Pearce J, Young IS. Absorption and antioxidant effects of quercetin from onions in man. 1999. Eur J Clin Nutr 53:92-96.
25. Metodiewa D, Jaiswal AK, Cenas N, Dickancaite E, Segura-Aguilar J. 1999. Quinone may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal products. Free Radic Biol Med 26:107-116.
26. Mochizuki M, Kajiya K, Terao J, Kaji K, Kumazawa S, Nakayama T, Shimoi K. 2004. Effect of quercetin conjugation on vascular permeability and expression of adhesion molecules. Biofactors 22:201-204.
27. Moon J-H, Tsushida T, Nakahara K, Terao J. 2001. Identification of quercetin 3-O-bglucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin. Free Radic Biol Med 30:1274-1285.
28. Moon J-H, Nakata R, Oshima S, Inakuma T, Terao J. 2000. Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women. Am J Physiol 279: R461-R467.
29. Mullen W, Boitier A, Stewart AJ, Crozier A. 2004. Flavonoid metabolites in human plasma and urine after the consumption of red onions: analysis by liquid chromatography with photodiode array and full scan tandem mass spectrometric detection. J Chromatogr A 1058:163-168.
30. Murakami A, Ashida H, Terao J. 2008. Multitargeted cancer prevention by quercetin. Cancer Lett. 269:315-325.
31. Murota K and Terao J. 2005. Quercetin appears in the lymph of unanesthetized rats as its phase II metabolites after administered into the stomach. FEBS Lett 579:5343-5346.
32. Murota K, Terao J. 2003. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch Biochem Biophys 417:12-17.
33. Murota K, Hotta A, Ido H, Kawai Y, Moon J-H, Sekido K, Hayashi H, Inakuma T, Terao J. 2007. Antioxidant capacity of albumin-bound quercetin metabolites after onion consumption in humans. J Med Invest 54:37-374.
34. O'Leary KA, de Pascual-Teresa S, Needs PW, Bao YP, O'Brien NM, Williamson G. 2004. Effect of flavonoids and vitamin E on cyclooxygenase-2(COX-2) transcription. Mutation Res 38:877-884.
35. Papadopoulou A, Green RJ, Frazier RA. 2005. Interaction of flavonoids with bovine serum albumin: A fluorescence quenching study. J Agric Food Chem 53:158-163.
36. Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. 2008. The antioxidant properties of serum albumin. FEBS Lett. 582:1783-1787.
37. Rusznyak S, Szent-Györgyi A. 1936. Vitamin nature of flavones. Nature 138:798.
38. Scalbert A, Williamson G. 2000. Dietary intake and bioavailability of polyphenols. J Nutr 130:2073S-2085S.
39. Shiba Y, Kinoshita T, Chuman H, Taketani Y, Takeda E, Kato Y, Naito M, Kawabata K, Ishisaka A, Terao J, Kawai Y. 2008. Flavonoids as substrates and inhibitors of myeloperoxidase: Molecular actions of aglycone and the metabolites. Chem Res Toxicol. 21:16-1609.
40. Shimoi K, Saka N, Nozawa R, Sato M, Amano I, Nakayama T, Kinae N 2001. Deglucuronidation of a flavonoid, luteolin monoglcucuronide, during inflammation. Drug Metab Disposition 29:1521-1524.
41. Spencer JP, Abd-el-Mohsen, Rice-Evans MC. 2004. Cellular uptake and metabolism of flavonoids and their metabolites: Implications for their bioactivity. Arch Biochem Biophys 423:148-161.
42. Steffen, Y, Gruber C, Schewe T, Sies H. 2008. Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem Biophys 469:209-219.
43. Sugimura T, Nagao MT, Matsushima T. 1977. Mutagenicity of flavone derivatives. Proc Japan Acad B53:194-197.
44. Terao J. 1999. Dietary flavonoids as plasma antioxidants on lipid peroxidation: Significance of metabolic conversion In: Packer L, Hiramatsu M, Yoshikawa T, Eds. Antioxidant Food Supplements in Human Health. San Diego: Academic Press, pp. 255-269.
45. Terao J, Piskula M. 1997. Flavonoid as inhibitors of lipid peroxidation in membranes. In: Rice-Evans CA, Packer L, Eds. Flavonoids in Health and Disease. New York: Marcel Dekker, pp. 277-294.
46. van de Woude H, Boersma MG, Vervoort J, Rietjens IMCM. 2004. Identification of 14 quercetin phase II mono and mixed conjugates and their formation by rat and human phase II in vitro model systems. Chem Res Toxicol 17:1520-1530.
47. Walle T. 2004. Absorption and metabolism of flavonoids. Free Radic Biol Med 36: 829-837.
48. Walle, T, Browning AM, Steed LL, Reed SG, Walle UK. 2005. Flavonoid glucosides are hydrolyzed and activated in the oral cavity in humans. J Nutr 135:48-52.
49. Walle T, Otake Y, Walle UK, Wilson FA. 2000. Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption. J Nutr 130:2658-2661.
50. Wayner DD, Burton GW, Ingold KU Barclay LR Locke SJ. 1987. The relative contributions to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta 924:408-419.
51. Williamson G, Barron D, Shimoi K, Terao J. 2005. In vitro biological properties of flavonoid conjugates found in vivo. Free Radic Res 39:457-459.
52. Yoshizumi M, Tsuchiya K, Suzaki Y, Kirima K, Kya M, Moon JH, Terao J, Tamaki T. 2002. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem Biophys Res Commun 293:1458-1465.
53. Youdin KA, Shukitt-Hale B, Joseph J. 2004. Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic Biol Med 37:1683-1693.